Tag: Covid-19
-
Trial Shows Broad Coronavirus Immune Response
Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses.
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
-
NIH Funding Single Home Test for Covid-19, Influenza, RSV
A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases.
-
Vaccine Patch Shown Safe, Induces Immune Response
Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response.
-
Infographic – More US Support for Childhood Vaccines Than Covid-19
A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines.
-
Low-Dose Covid-19 Vaccine Generates Strong Immune Response
Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses.
-
Biotech Gains $53.7M Infectious Disease Test Award
A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections.
-
Self-Applied Patch Shown Feasible for Vaccine Delivery
A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians.
-
Chewable Covid-19 Drug Reduces Viral Load, Symptoms
Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease.
-
Home Infectious Disease Diagnostic Begins Clinical Tests
A company offering DNA analysis tests to detect infectious diseases at home and point-of-care is beginning clinical evaluations of its technology.